Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Sheba Joins Peter MacCallum Cancer Center for a New Prostate Cancer Treatment Trial

Sheba Medical Center and Peter MacCallum Center work on a joint trial of a new prostate cancer treatment.
The two medical centers will collaborate on a new trial designed to evaluate innovative treatments for men suffering from advanced prostate cancer.

The POPSTAR II clinical trial, due to begin in early 2023 at multiple sites, will compare two cutting-edge treatments for men with advanced prostate cancer – lutetium PSMA (LuPSMA) therapy and stereotactic ablative radiotherapy (SABR). During a recent visit to Australia, Sheba’s Director General, Prof. Yitshak Kreiss, signed a letter of intent making Sheba an international partner for the new trial.

After visiting Israel, Peter Mac Chief Executive. Prof. Shelley Dolan described this latest agreement as another example of the growing international relationship between two leading institutions.

“The international expansion of this clinical trial will boost access for men to innovative new prostate cancer treatments,” Prof. Dolan explained. “Following the signing of an MOU between Peter Mac and Sheba Medical Center, it is fantastic to see that it is being implemented for the benefit of people with cancer internationally.”

The aforementioned MOU was signed in May when both organizations agreed to collaborate on innovation and commercialization opportunities, research and scientific collaborations, educational and training opportunities, fellowship programs, staff exchanges, and more.

Commenting on the new agreement, Professor Kreiss stressed: “We see our collaboration with Peter Mac as an important step toward strengthening our relationship with the Victorian Government in relation to innovation and clinical research. Peter Mac is an elite institution that is a leader in research and the development of novel treatments. It endeavors to change the future of medicine, mirroring Sheba’s vision via our ARC innovation center.”

Home to some of the world’s top experts in cancer research, and prostate cancer in particular, Sheba is proud to play a leading role in the development of advanced therapies for the benefit of patients worldwide.

Sheba Shines in Forbes Israel's 2024 Best Doctors List
Forbes Israel's 2024 list includes 186 specialties and subspecialties, featuring 1,386 doctors from medical centers, institutions, and hospitals across the country. Sheba Medical Center leads…
Read More
Tristan with Dr. David Mishali
A Heart Like No Other: Tristan’s Ten Year Triumph with Sheba
It was ten years ago when a tiny heartbeat held a massive secret. Tristan, a lively little boy, was born with congenital heart disease and given only minutes to live. Thanks to Sheba, those few minutes turned into a decade of a vibrant life.
Read More
RWJBarnabas Health and ARC Innovation Collaborate on HealthSpace2030
Last week, ARC Innovation announced a new partnership with RWJBarnabas Health. They will act as an anchoring partner for its innovation hub, HealthSpace2030, a Jersey…
Read More